Literature DB >> 11732933

Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study.

I Lemieux1, B Lamarche, C Couillard, A Pascot, B Cantin, J Bergeron, G R Dagenais, J P Després.   

Abstract

BACKGROUND: Total cholesterol (TC)/high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C)/HDL-C ratios are used to predict ischemic heart disease risk. There is, however, no consensus on which of these 2 indices is superior. The objective of the present study was to present evidence that the LDL-C/HDL-C ratio may underestimate ischemic heart disease risk in overweight hyperinsulinemic patients with high triglyceride (TG)-low HDL-C dyslipidemia.
METHODS: A total of 2103 middle-aged men in whom measurements of the metabolic profile were performed in the fasting state were recruited from 7 suburbs of the Quebec metropolitan area.
RESULTS: The relationship of LDL-C/HDL-C to TC/HDL-C ratios was examined among men in the Quebec Cardiovascular Study classified into tertiles of fasting TG levels. For any given LDL-C/HDL-C ratio, the TC/HDL-C ratio was higher among men in the top TG tertile (>168 mg/dL [>1.9 mmol/L]) than in men in the first and second TG tertiles. Adjustment of the TC/HDL-C ratio for LDL-C/HDL-C by covariance analysis generated significant differences in average TC/HDL-C ratios among TG tertiles (P<.001). Greater differences in features of the insulin resistance syndrome (insulinemia, apolipoprotein B, and LDL size) were noted across tertiles of the TC/HDL-C ratio than tertiles of the LDL-C/HDL-C ratio.
CONCLUSION: Variation in the TC/HDL-C ratio may be associated with more substantial alterations in metabolic indices predictive of ischemic heart disease risk and related to the insulin resistance syndrome than variation in the LDL-C/HDL-C ratio.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11732933     DOI: 10.1001/archinte.161.22.2685

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  125 in total

1.  Evaluation and management of atherogenic dyslipidemia: beyond low-density lipoprotein cholesterol.

Authors:  J P Després; I Lemieux; G R Dagenais; B Cantin; B Lamarche
Journal:  CMAJ       Date:  2001-11-13       Impact factor: 8.262

2.  Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis.

Authors:  M Boers; M T Nurmohamed; C J A Doelman; L R Lard; A C Verhoeven; A E Voskuyl; T W J Huizinga; R J van de Stadt; B A C Dijkmans; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

3.  Oral Azelaic Acid Ester Decreases Markers of Insulin Resistance in Overweight Human Male Subjects.

Authors:  Robert T Streeper; Elzbieta Izbicka; Christopher Louden
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 4.  Lipid parameters for measuring risk of cardiovascular disease.

Authors:  Benoit J Arsenault; S Matthijs Boekholdt; John J P Kastelein
Journal:  Nat Rev Cardiol       Date:  2011-02-01       Impact factor: 32.419

Review 5.  Biomarkers related to aging in human populations.

Authors:  Eileen Crimmins; Sarinnapha Vasunilashorn; Jung Ki Kim; Dawn Alley
Journal:  Adv Clin Chem       Date:  2008       Impact factor: 5.394

6.  Metabolic syndrome components and sudden sensorineural hearing loss: a case-control study.

Authors:  Mir Mohammad Jalali; Mahsa Nasimidoust Azgomi
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-24       Impact factor: 2.503

7.  Twentieth century surge of excess adult male mortality.

Authors:  Hiram Beltrán-Sánchez; Caleb E Finch; Eileen M Crimmins
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-06       Impact factor: 11.205

8.  Overweight and obesity are progressively associated with lower work ability in the general working population: cross-sectional study among 10,000 adults.

Authors:  Lars L Andersen; Mikel Izquierdo; Emil Sundstrup
Journal:  Int Arch Occup Environ Health       Date:  2017-06-28       Impact factor: 3.015

9.  Changes in regional adiposity and cardio-metabolic function following a weight loss program with sibutramine in obese men with obstructive sleep apnea.

Authors:  Craig L Phillips; Brendon J Yee; Mike I Trenell; John S Magnussen; David Wang; Dev Banerjee; Norbert Berend; Ronald R Grunstein
Journal:  J Clin Sleep Med       Date:  2009-10-15       Impact factor: 4.062

10.  Association of lipids with incident heart failure among adults with and without diabetes mellitus: Multiethnic Study of Atherosclerosis.

Authors:  Imo A Ebong; David C Goff; Carlos J Rodriguez; Haiying Chen; Christopher T Sibley; Alain G Bertoni
Journal:  Circ Heart Fail       Date:  2013-03-25       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.